COVID-19 and Acute Pancreatitis: Not Increased Risk but Reduced Care

IF 1.5 Q3 GASTROENTEROLOGY & HEPATOLOGY Gastroenterology Insights Pub Date : 2023-11-08 DOI:10.3390/gastroent14040039
Michele Cevolani, Marco Ferronato, Chiara Elide Lizzio, Eleonora Elia, Desy Marini, Elena Mazzotta, Claudio Ricci, Riccardo Casadei, Marina Migliori
{"title":"COVID-19 and Acute Pancreatitis: Not Increased Risk but Reduced Care","authors":"Michele Cevolani, Marco Ferronato, Chiara Elide Lizzio, Eleonora Elia, Desy Marini, Elena Mazzotta, Claudio Ricci, Riccardo Casadei, Marina Migliori","doi":"10.3390/gastroent14040039","DOIUrl":null,"url":null,"abstract":"Background and aim: Over the last few years, SARS-CoV-2 has been reported as a possible cause of acute pancreatitis (AP), but whether it is a relevant clinical–epidemiological entity is still a matter of debate. We aim to evaluate the epidemiological characteristics of AP during the first year of the COVID pandemic (2020) and compare them with the pre-COVID period (2008–2019) to identify any differences and clarify a potential causative role of SARS-CoV-2. Methods: We used a monocentric retrospective study of 132 AP patients during 2020 and 1987 AP patients during 2008–2019. Diagnosis and severity were classified according to the revised Atlanta criteria. Propensity score matching was performed according to clinical–epidemiological features, and outcome analysis was performed on two subgroups of 109 patients. Results: The total number of AP cases in 2020 is one of the lowest in the last 13 years (132 cases, median 161, IQR 146-183). No major epidemiological differences were noted. During 2020, we observed a significant modification of the distribution of etiologies (p < 0.001), mainly based on a decrease in biliary forms (59.6% vs. 43.2%) and an increase in alcoholic forms (6.9% vs. 12.9%). Idiopathic forms remain unchanged (20.5% vs. 21.9%). The proportion of AP of idiopathic etiology and SARS-CoV-2 infection was 0.008%. There were no differences in terms of severity distribution (p = 0.127), length of stay (p = 0.916), need for ICU (p = 0.139), or mortality (p = 0.462). Even among statistically matched groups, there were no differences between the length of stay (9 vs. 10 days, p = 0.890), need for ICU admission (1.8% vs. 3.7%, p = 0.683), or in-hospital mortality (0 vs. 1.8%, p = 0.342). Conclusions: The lower AP diagnoses indicate delayed and likely missed diagnoses, probably because of both hesitancy and organizational problems during the pandemic. The unchanged proportion of idiopathic forms supports the hypothesis that SARS-CoV-2 is not an AP trigger.","PeriodicalId":43586,"journal":{"name":"Gastroenterology Insights","volume":"48 12","pages":"0"},"PeriodicalIF":1.5000,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterology Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/gastroent14040039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: Over the last few years, SARS-CoV-2 has been reported as a possible cause of acute pancreatitis (AP), but whether it is a relevant clinical–epidemiological entity is still a matter of debate. We aim to evaluate the epidemiological characteristics of AP during the first year of the COVID pandemic (2020) and compare them with the pre-COVID period (2008–2019) to identify any differences and clarify a potential causative role of SARS-CoV-2. Methods: We used a monocentric retrospective study of 132 AP patients during 2020 and 1987 AP patients during 2008–2019. Diagnosis and severity were classified according to the revised Atlanta criteria. Propensity score matching was performed according to clinical–epidemiological features, and outcome analysis was performed on two subgroups of 109 patients. Results: The total number of AP cases in 2020 is one of the lowest in the last 13 years (132 cases, median 161, IQR 146-183). No major epidemiological differences were noted. During 2020, we observed a significant modification of the distribution of etiologies (p < 0.001), mainly based on a decrease in biliary forms (59.6% vs. 43.2%) and an increase in alcoholic forms (6.9% vs. 12.9%). Idiopathic forms remain unchanged (20.5% vs. 21.9%). The proportion of AP of idiopathic etiology and SARS-CoV-2 infection was 0.008%. There were no differences in terms of severity distribution (p = 0.127), length of stay (p = 0.916), need for ICU (p = 0.139), or mortality (p = 0.462). Even among statistically matched groups, there were no differences between the length of stay (9 vs. 10 days, p = 0.890), need for ICU admission (1.8% vs. 3.7%, p = 0.683), or in-hospital mortality (0 vs. 1.8%, p = 0.342). Conclusions: The lower AP diagnoses indicate delayed and likely missed diagnoses, probably because of both hesitancy and organizational problems during the pandemic. The unchanged proportion of idiopathic forms supports the hypothesis that SARS-CoV-2 is not an AP trigger.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19和急性胰腺炎:不是增加风险,而是减少护理
背景和目的:在过去的几年中,SARS-CoV-2被报道为急性胰腺炎(AP)的可能原因,但它是否是相关的临床流行病学实体仍然存在争议。我们的目标是评估COVID大流行第一年(2020年)AP的流行病学特征,并将其与COVID前时期(2008-2019年)进行比较,以确定任何差异并阐明SARS-CoV-2的潜在致病作用。方法:我们对2020年的132例AP患者和2008-2019年的1987例AP患者进行了单中心回顾性研究。根据修订的亚特兰大标准对诊断和严重程度进行分类。根据临床流行病学特征进行倾向评分匹配,并对109例患者的两个亚组进行结局分析。结果:2020年AP总病例数为近13年来最低之一(132例,中位数161例,IQR 146 ~ 183例)。没有注意到主要的流行病学差异。在2020年期间,我们观察到病因分布发生了重大变化(p <0.001),主要基于胆道形式的减少(59.6%对43.2%)和酒精形式的增加(6.9%对12.9%)。特发性形式保持不变(20.5% vs. 21.9%)。特发性病因和SARS-CoV-2感染的AP比例为0.008%。在严重程度分布(p = 0.127)、住院时间(p = 0.916)、重症监护病房(p = 0.139)和死亡率(p = 0.462)方面均无差异。即使在统计上匹配的组中,住院时间(9天对10天,p = 0.890)、ICU住院需求(1.8%对3.7%,p = 0.683)和住院死亡率(0对1.8%,p = 0.342)之间也没有差异。结论:较低的AP诊断表明延迟诊断和可能漏诊,可能是由于大流行期间的犹豫和组织问题。特发性形式的比例不变支持了SARS-CoV-2不是AP触发因素的假设。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gastroenterology Insights
Gastroenterology Insights GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
2.80
自引率
3.40%
发文量
35
审稿时长
10 weeks
期刊最新文献
Correlation between Interleukin-17, High Sensitivity C-Reactive Protein and Pepsinogen in Helicobacter pylori Infected Gastritis Elevated Incidence and Risk of Emergent Cirrhosis Complications in Alcoholic Cirrhosis Compared with Other Etiologies Insights into the Characteristics and Functions of Mast Cells in the Gut Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1